מודיקיט MR כמוסות בשחרור מושהה 30 מ"ג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

METHYLPHENIDATE HYDROCHLORIDE 30 MG

Commercializzato da:

MEDILINE LTD.

Codice ATC:

N06BA04

Forma farmaceutica:

MODIFIED RELEASE CAPSULES

Via di somministrazione:

PER OS

Prodotto da:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

Gruppo terapeutico:

METHYLPHENIDATE

Indicazioni terapeutiche:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient.Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

Data dell'autorizzazione:

2011-05-01